Quarterly report pursuant to Section 13 or 15(d)

Fair Value of Financial Instruments - Narrative (Details)

v3.22.2
Fair Value of Financial Instruments - Narrative (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]        
Unrealized gain (loss) included in OCI $ 0   $ 0  
Specialty Chemicals Segment        
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]        
Asset impairments   $ 200,000   $ 200,000